(Q59566056)
Statements
A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy (English)
Shirish Gadgeel
Ivan Rothman
Bruce Saidman
Kert Sabbath
Kevie Feit
Gregory J Riely
Naiyer A Rizvi
7 November 2006